Strategy Workshop & Summer Party 2025

Earlier this month, the Staburo team gathered for a full-day strategy workshop followed by our much-anticipated summer party. In the morning, we joined our workshop groups previously assigned. Topics such as: Ethical and Respectful Leadership, Empathetic and Supportive Culture, Growth and Development, Empowerment and Autonomy, and Strategic and Sustainable Business Focus were discussed to explore how we live our values and sharpen our strategy for the months ahead. Lively debates yielded a set of clear recommendations that will guide our priorities.

This year we also introduced a poster challenge: each group gathered their top recommendations onto creative, eye-catching posters. By lunch time, they brought their concepts to life in colourful visuals, infographics and snappy taglines. In a lively end-of-workshop showcase, participants toured each display, asked questions and voted for their favourites.

After our working day, we moved into the ground-floor courtyard for our summer party. The barbecue was fired up for party and conversations started to flow. Even a sudden rain shower couldn’t dampen spirits – instead, colleagues and family members settled under umbrellas and on the inside venue, cheering each other on through photo challenges, lawn games and table tennis.

Whether in focused workshops or festivities, nothing brings us closer than the chance to learn, grow and celebrate together. Here’s to putting our new insights into action and to many more memorable moments at Staburo!

Staburo At The BIO Conference 2025

Staburo GmbH was represented by our Managing Director, Roland Stieger, at the Biotechnology Innovation Organization (BIO) International Convention from June 16-19, 2025, in Boston. It was an exceptional opportunity to connect with full-service CROs, biotech and big pharma companies, all of whom share our commitment to advancing the future of healthcare. 

Our presence at this event allowed us to showcase Staburo’s expertise in biostatistics, statistical programming, and data management – core areas where we have established a reputation as a trusted strategic partner. The insightful discussions we engaged in, highlighted the value of our tailored solutions, which are designed to support both ongoing and future projects. We were excited to demonstrate how Staburo can streamline complex biostatistics and data management processes, ultimately driving the success of biotech companies in a rapidly evolving market. 

The convention also provided an invaluable platform to forge new partnerships and strengthen existing relationships. We are thrilled with the productive conversations that took place and are excited about the collaborations already in the pipeline. At Staburo, we remain committed to continuing these discussions and providing ongoing support to our partners as they advance research and development efforts. 

We look forward to seeing the lasting impact of the connections made in Boston!

Staburo At The PSI Conference 2025

From June 8th to 11th, 2025, Staburo was excited to participate in the highly anticipated PSI Annual Conference, held in Wembley, London. This event, considered one of the most important gatherings in the pharmaceutical and healthcare sectors, brought together a diverse community of professionals of this industry. With its focus on innovation and cutting-edge advancements in drug development and precision medicine, the conference provided an invaluable platform for sharing knowledge, fostering collaboration, and exploring the future of healthcare. 

Among the many highlights of the event was the presentation of a poster titled “Machine Learning in Precision Medicine: A Collaborative Approach.” This work was the result of a concerted effort by the Machine Learning workstream of the PSI Biomarker European Special Interest Group (ESIG), with Staburo’s Director Biostatistics Focus Area Biomarker, Laura Schlieker playing a central role in the presentation. The poster sparked engaging discussions on how machine learning technologies can be integrated into biomarker-driven strategies to accelerate the development of personalized treatments. The presentation was met with great enthusiasm and was honoured with one of the four Best Poster awards, recognizing the significance of the work in advancing the field. 

The conference also served as a valuable opportunity for the members of the Biomarker ESIG to come together in person, strengthening existing partnerships and opening the door to new collaborations. 

At Staburo, we are deeply committed to advancing innovative research that bridges the gap between machine learning and biomarker-driven approaches. Our participation in the PSI Annual Conference as well as the Biomarkers ESIG underscores our ongoing efforts to be at the forefront of scientific discovery and to collaborate with like-minded experts in the pursuit of better, more tailored healthcare solutions. 

Business Unit Team Event 2025

Our business unit (as we call our corporate functions team—bringing HR, Finance, IT, Business Development, Quality and Office Management under one unified vision) gathered recently for a flavourful evening of fun, food, and fantastic company at Eataly in Munich and what a night it was! 

After leaving the office, we kicked off the evening with a warm welcome of drinks, and delicious appetizers. The main highlight? A hands-on pasta cooking class, where we rolled up our sleeves and tied on our aprons to make fresh Tagliatelle from scratch. 

With some Italian spirit and fantastic teamwork, we succeeded in creating some truly impressive pasta. Followed, of course, by a well-earned dinner featuring our own homemade creations, paired with wine and topped off with a sweet dessert to finish the night. 

From laughter in the kitchen to great conversations around the table, the event was a wonderful opportunity to connect outside of our usual work setting and strengthen our team spirit. 

A huge thank you to everyone who joined and helped make the evening such a success. 

Here’s to more great moments together both in and out of the office! 

Staburo At ICH E6 (R3) Training 

We were delighted to welcome two highly experienced trainers, Dr. Andreas Berk and Helge Bonaventura from InnovationTriologie, to our Munich office for an engaging hybrid training session on the updated ICH E6 (R3) guideline. The training offered a comprehensive look at both GCP basic principles and the key changes from ICH E6 (R2) to the new R3 version, making it valuable for colleagues at all levels of experience. 

The friendly and open atmosphere encouraged participants to ask interesting questions and share their perspectives, enriching the learning experience for everyone. 

A coffee break offered the chance to network and reflect on the morning’s content, and we enjoyed a relaxed lunch afterwards with the trainers, providing further opportunity for exchange in an informal setting. 

We would like to thank Dr. Andreas Berk and Helge Bonaventura for their expert guidance and Q&A opportunity after the session, and all attendees for their active participation.  

At Staburo, we prioritise maintaining awareness of evolving regulatory requirements, as they form a fundamental part of our commitment to quality and excellence in clinical research. 

Staburo welcomes its 100th employee

We’re proud to announce an important milestone in our company’s journey. Staburo GmbH has officially grown to a team of over 100 professionals! This achievement is more than just a number — it reflects our ongoing commitment to delivering high-quality health data science solutions.

From our early days, we are a trusted partner for pharmaceutical, CRO, and biotech companies.

This milestone is a testament to the impact of our team’s work and the strength of the collaborations we’ve built over the years.

We are incredibly thankful to our clients who have placed their trust in us, and to every team member who has helped shape Staburo into what it is today.

As we look toward the future, we remain committed our core purpose: Excellent data science to save and improve lives